NCT02132637View on ClinicalTrials.gov

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Insulin Peglispro

Administered SQ

DRUG

Insulin Glargine

Administered SQ

Trial Locations (3)

41460

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Neuss

55116

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mainz

91911

Profil Institute for Clinical Research Inc, Chula Vista

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02132637 - A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes | Biotech Hunter | Biotech Hunter